Carcinoma, Medullary - 17 Studies Found

Terminated : Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
:
  • Thyroid Neoplasm
  • Thyroid Carcinoma
  • M
    : 2008-03-26
    : Other: 18F-L-DOPA PET PET performed 30 minutes after IV injection of 4 MBq/kg of 18F-DOPA
Active, not recruiting : Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
:
  • Multiple Endocrine Neoplasia
  • Recurrent Thyroid Gland Carcinoma
  • Other: Laboratory Biomarker Analysis

Recruiting : Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
:
  • Carcinoma of the Collecting Ducts of Bellini
  • Chromophobe Renal Cell Carcinoma
  • : 2013-01-10
    : Drug: Pazopanib Hydrochloride Given PO Other Names:
Active, not recruiting : Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
:
  • Recurrent Thyroid Gland Carcinoma
  • Stage III Differentiated Thyroid Gland Carcinoma
  • : 2008-02-27
    :
    • Other: Laboratory Biomarker Analysis

Active, not recruiting : Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
:
  • Childhood Solid Neoplasm
  • Childhood Thyroid Gland Medullary Carcinoma : 2012-10-16
    :
    • Drug: Cabozantinib S-malate Gi
Completed : Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer
:
  • Insular Thyroid Cancer
  • Recurrent Thyroid Cancer
  • Stage II F
    : 2005-08-22
    : Drug: vorinostat Given orally Other Names:
Recruiting : A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
:
  • Malignant Rhabdoid Tumors (MRT)
  • Rhabdoid Tumors of the Kidney (RTK)
  • Adult Acute Myeloid Leukemia in Remission
  • Childhood Acute Lymphoblastic Leukemia in Remissio
    : 2001-12-07
    :
    • Drug: Fludarabine Phosphate Gi
Recruiting : Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
:
  • Breast Cancer
  • Colon Cancer
  • Extrahepatic Bile Duct Cancer : 2014-10-09
    :
    • Procedure: radionuclide imaging

Completed : Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
:
  • Gastrin-Producing Neuroendocrine Tumor
  • Lung Carcinoid Tumor
  • Biological: Cixutumumab Given

Next >>>